AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ACETAZOLAMIDE
18 registrations across 7 African markets— 16 active
Markets with ACETAZOLAMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Occumox Tablets_ Tablet | 🇳🇬Nigeria | Fanyval Visions Limited | active | Jun 2030 |
| ACETAZOLAMIDE TABLET; ORAL | 🇿🇼Zimbabwe | REMEDICA LTD | active | Dec 2027 |
| APO-ACETAZOLAMIDE TABLET; ORAL | 🇿🇼Zimbabwe | AA PHARMA INC | active | Dec 2027 |
| Acetazolamide 250 mg Tablet** Tablet | 🇳🇬Nigeria | Mankind Life-Sciences Limited | active | Aug 2026 |
| Acetazolamide 250 Tablets_ Tablet | 🇳🇬Nigeria | Fidson Healthcare PLC | active | Feb 2026 |
| Zolamox 250 Tablet** Tablet | 🇳🇬Nigeria | Biomedicine Sckivs Pharmaceutical Nigeria Limited | active | Jan 2026 |
| DIAMOX 250 MG Comprimé / 250 mg | 🇹🇳Tunisia | COOPERATION PHARMACEUTIQUE FRANCAISE | expired | May 2020 |
| AZOMID 250MG TABLETS TABLETS | 🇲🇼Malawi | — | expired | Jun 2014 |
| DIAMOX COMPRIME SECABLE | 🇲🇦Morocco | — | active | — |
| ACETAZOLAMIDE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | REMEDICA LTD | active | — |
| ACETAZOLAMIDE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | CENTAUR PHARMACEUTICA LS PVT. LTD | active | — |
| ACETAZOLAMIDE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | REMEDICA LTD | active | — |
| ACETAZOLAMIDE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | REMEDICA LTD | active | — |
| ACETAZOLAMIDE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | CENTAUR PHARMACEUTICA LS PVT. LTD | active | — |
| ACETAZOLAMIDE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | CENTAUR PHARMACEUTICA LS PVT. LTD | active | — |
| Acetazolamide Tablets | 🇹🇿Tanzania | Remedica LTD | active | — |
| ACETAZOLAMIDE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | REMEDICA LTD | active | — |
| ACETAZOLAMIDE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | CENTAUR PHARMACEUTICA LS PVT. LTD | active | — |
ACETAZOLAMIDE in Africa — Regulatory Overview
ACETAZOLAMIDE is registered across 7 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Nigeria, Zimbabwe, Tanzania and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 16 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.